nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadoteridol—Oedema—Irinotecan—lung cancer	0.00159	0.00159	CcSEcCtD
Gadoteridol—Erythema—Paclitaxel—lung cancer	0.00159	0.00159	CcSEcCtD
Gadoteridol—Feeling abnormal—Vinorelbine—lung cancer	0.00159	0.00159	CcSEcCtD
Gadoteridol—Diarrhoea—Vinblastine—lung cancer	0.00158	0.00158	CcSEcCtD
Gadoteridol—Dysgeusia—Etoposide—lung cancer	0.00158	0.00158	CcSEcCtD
Gadoteridol—Pruritus—Erlotinib—lung cancer	0.00157	0.00157	CcSEcCtD
Gadoteridol—Shock—Irinotecan—lung cancer	0.00156	0.00156	CcSEcCtD
Gadoteridol—Dysgeusia—Paclitaxel—lung cancer	0.00155	0.00155	CcSEcCtD
Gadoteridol—Rhinitis—Docetaxel—lung cancer	0.00155	0.00155	CcSEcCtD
Gadoteridol—Anaphylactic shock—Gemcitabine—lung cancer	0.00155	0.00155	CcSEcCtD
Gadoteridol—Oedema—Gemcitabine—lung cancer	0.00155	0.00155	CcSEcCtD
Gadoteridol—Diarrhoea—Topotecan—lung cancer	0.00154	0.00154	CcSEcCtD
Gadoteridol—Hyperhidrosis—Irinotecan—lung cancer	0.00153	0.00153	CcSEcCtD
Gadoteridol—Dizziness—Vinblastine—lung cancer	0.00153	0.00153	CcSEcCtD
Gadoteridol—Convulsion—Cisplatin—lung cancer	0.00153	0.00153	CcSEcCtD
Gadoteridol—Urticaria—Vinorelbine—lung cancer	0.00153	0.00153	CcSEcCtD
Gadoteridol—Diarrhoea—Erlotinib—lung cancer	0.00152	0.00152	CcSEcCtD
Gadoteridol—Abdominal pain—Vinorelbine—lung cancer	0.00152	0.00152	CcSEcCtD
Gadoteridol—Body temperature increased—Vinorelbine—lung cancer	0.00152	0.00152	CcSEcCtD
Gadoteridol—Ill-defined disorder—Etoposide—lung cancer	0.0015	0.0015	CcSEcCtD
Gadoteridol—Anxiety—Cisplatin—lung cancer	0.0015	0.0015	CcSEcCtD
Gadoteridol—Hyperhidrosis—Gemcitabine—lung cancer	0.00149	0.00149	CcSEcCtD
Gadoteridol—Dizziness—Topotecan—lung cancer	0.00149	0.00149	CcSEcCtD
Gadoteridol—Tremor—Paclitaxel—lung cancer	0.00149	0.00149	CcSEcCtD
Gadoteridol—Discomfort—Cisplatin—lung cancer	0.00148	0.00148	CcSEcCtD
Gadoteridol—Hypotension—Irinotecan—lung cancer	0.00148	0.00148	CcSEcCtD
Gadoteridol—Vomiting—Vinblastine—lung cancer	0.00147	0.00147	CcSEcCtD
Gadoteridol—Dizziness—Erlotinib—lung cancer	0.00147	0.00147	CcSEcCtD
Gadoteridol—Ill-defined disorder—Paclitaxel—lung cancer	0.00147	0.00147	CcSEcCtD
Gadoteridol—Malaise—Etoposide—lung cancer	0.00146	0.00146	CcSEcCtD
Gadoteridol—Headache—Vinblastine—lung cancer	0.00145	0.00145	CcSEcCtD
Gadoteridol—Hypotension—Gemcitabine—lung cancer	0.00144	0.00144	CcSEcCtD
Gadoteridol—Anaphylactic shock—Cisplatin—lung cancer	0.00144	0.00144	CcSEcCtD
Gadoteridol—Oedema—Cisplatin—lung cancer	0.00144	0.00144	CcSEcCtD
Gadoteridol—Anaphylactoid reaction—Doxorubicin—lung cancer	0.00144	0.00144	CcSEcCtD
Gadoteridol—Flushing—Docetaxel—lung cancer	0.00143	0.00143	CcSEcCtD
Gadoteridol—Vomiting—Topotecan—lung cancer	0.00143	0.00143	CcSEcCtD
Gadoteridol—Malaise—Paclitaxel—lung cancer	0.00143	0.00143	CcSEcCtD
Gadoteridol—Paraesthesia—Irinotecan—lung cancer	0.00142	0.00142	CcSEcCtD
Gadoteridol—Syncope—Paclitaxel—lung cancer	0.00142	0.00142	CcSEcCtD
Gadoteridol—Loss of consciousness—Etoposide—lung cancer	0.00142	0.00142	CcSEcCtD
Gadoteridol—Rash—Topotecan—lung cancer	0.00142	0.00142	CcSEcCtD
Gadoteridol—Hypersensitivity—Vinorelbine—lung cancer	0.00142	0.00142	CcSEcCtD
Gadoteridol—Dermatitis—Topotecan—lung cancer	0.00142	0.00142	CcSEcCtD
Gadoteridol—Vomiting—Erlotinib—lung cancer	0.00141	0.00141	CcSEcCtD
Gadoteridol—Dyspnoea—Irinotecan—lung cancer	0.00141	0.00141	CcSEcCtD
Gadoteridol—Cough—Etoposide—lung cancer	0.00141	0.00141	CcSEcCtD
Gadoteridol—Headache—Topotecan—lung cancer	0.00141	0.00141	CcSEcCtD
Gadoteridol—Rash—Erlotinib—lung cancer	0.0014	0.0014	CcSEcCtD
Gadoteridol—Dermatitis—Erlotinib—lung cancer	0.0014	0.0014	CcSEcCtD
Gadoteridol—Convulsion—Etoposide—lung cancer	0.0014	0.0014	CcSEcCtD
Gadoteridol—Hypertension—Etoposide—lung cancer	0.0014	0.0014	CcSEcCtD
Gadoteridol—Headache—Erlotinib—lung cancer	0.00139	0.00139	CcSEcCtD
Gadoteridol—Loss of consciousness—Paclitaxel—lung cancer	0.00139	0.00139	CcSEcCtD
Gadoteridol—Hyperhidrosis—Cisplatin—lung cancer	0.00139	0.00139	CcSEcCtD
Gadoteridol—Paraesthesia—Gemcitabine—lung cancer	0.00139	0.00139	CcSEcCtD
Gadoteridol—Cough—Paclitaxel—lung cancer	0.00138	0.00138	CcSEcCtD
Gadoteridol—Dyspnoea—Gemcitabine—lung cancer	0.00138	0.00138	CcSEcCtD
Gadoteridol—Chest pain—Etoposide—lung cancer	0.00138	0.00138	CcSEcCtD
Gadoteridol—Nausea—Vinblastine—lung cancer	0.00138	0.00138	CcSEcCtD
Gadoteridol—Convulsion—Paclitaxel—lung cancer	0.00137	0.00137	CcSEcCtD
Gadoteridol—Hypertension—Paclitaxel—lung cancer	0.00137	0.00137	CcSEcCtD
Gadoteridol—Pruritus—Vinorelbine—lung cancer	0.00136	0.00136	CcSEcCtD
Gadoteridol—Discomfort—Etoposide—lung cancer	0.00136	0.00136	CcSEcCtD
Gadoteridol—Pain—Irinotecan—lung cancer	0.00136	0.00136	CcSEcCtD
Gadoteridol—Chest pain—Paclitaxel—lung cancer	0.00135	0.00135	CcSEcCtD
Gadoteridol—Hypotension—Cisplatin—lung cancer	0.00135	0.00135	CcSEcCtD
Gadoteridol—Anxiety—Paclitaxel—lung cancer	0.00135	0.00135	CcSEcCtD
Gadoteridol—Face oedema—Doxorubicin—lung cancer	0.00134	0.00134	CcSEcCtD
Gadoteridol—Erythema—Docetaxel—lung cancer	0.00134	0.00134	CcSEcCtD
Gadoteridol—Nausea—Topotecan—lung cancer	0.00134	0.00134	CcSEcCtD
Gadoteridol—Discomfort—Paclitaxel—lung cancer	0.00133	0.00133	CcSEcCtD
Gadoteridol—Cardiac arrest—Doxorubicin—lung cancer	0.00132	0.00132	CcSEcCtD
Gadoteridol—Pain—Gemcitabine—lung cancer	0.00132	0.00132	CcSEcCtD
Gadoteridol—Nausea—Erlotinib—lung cancer	0.00132	0.00132	CcSEcCtD
Gadoteridol—Dry mouth—Paclitaxel—lung cancer	0.00132	0.00132	CcSEcCtD
Gadoteridol—Anaphylactic shock—Etoposide—lung cancer	0.00132	0.00132	CcSEcCtD
Gadoteridol—Diarrhoea—Vinorelbine—lung cancer	0.00132	0.00132	CcSEcCtD
Gadoteridol—Dysgeusia—Docetaxel—lung cancer	0.00132	0.00132	CcSEcCtD
Gadoteridol—Feeling abnormal—Irinotecan—lung cancer	0.00131	0.00131	CcSEcCtD
Gadoteridol—Oedema—Paclitaxel—lung cancer	0.00129	0.00129	CcSEcCtD
Gadoteridol—Anaphylactic shock—Paclitaxel—lung cancer	0.00129	0.00129	CcSEcCtD
Gadoteridol—Paraesthesia—Cisplatin—lung cancer	0.00129	0.00129	CcSEcCtD
Gadoteridol—Dyspnoea—Cisplatin—lung cancer	0.00128	0.00128	CcSEcCtD
Gadoteridol—Hyperhidrosis—Etoposide—lung cancer	0.00128	0.00128	CcSEcCtD
Gadoteridol—Feeling abnormal—Gemcitabine—lung cancer	0.00127	0.00127	CcSEcCtD
Gadoteridol—Shock—Paclitaxel—lung cancer	0.00127	0.00127	CcSEcCtD
Gadoteridol—Dizziness—Vinorelbine—lung cancer	0.00127	0.00127	CcSEcCtD
Gadoteridol—Body temperature increased—Irinotecan—lung cancer	0.00125	0.00125	CcSEcCtD
Gadoteridol—Abdominal pain—Irinotecan—lung cancer	0.00125	0.00125	CcSEcCtD
Gadoteridol—Hyperhidrosis—Paclitaxel—lung cancer	0.00125	0.00125	CcSEcCtD
Gadoteridol—Hypotension—Etoposide—lung cancer	0.00123	0.00123	CcSEcCtD
Gadoteridol—Pain—Cisplatin—lung cancer	0.00123	0.00123	CcSEcCtD
Gadoteridol—Vomiting—Vinorelbine—lung cancer	0.00122	0.00122	CcSEcCtD
Gadoteridol—Body temperature increased—Gemcitabine—lung cancer	0.00122	0.00122	CcSEcCtD
Gadoteridol—Rash—Vinorelbine—lung cancer	0.00121	0.00121	CcSEcCtD
Gadoteridol—Dermatitis—Vinorelbine—lung cancer	0.00121	0.00121	CcSEcCtD
Gadoteridol—Hypotension—Paclitaxel—lung cancer	0.00121	0.00121	CcSEcCtD
Gadoteridol—Headache—Vinorelbine—lung cancer	0.00121	0.00121	CcSEcCtD
Gadoteridol—Syncope—Docetaxel—lung cancer	0.00121	0.00121	CcSEcCtD
Gadoteridol—Dysphagia—Doxorubicin—lung cancer	0.0012	0.0012	CcSEcCtD
Gadoteridol—Sweating—Methotrexate—lung cancer	0.00119	0.00119	CcSEcCtD
Gadoteridol—Feeling abnormal—Cisplatin—lung cancer	0.00119	0.00119	CcSEcCtD
Gadoteridol—Paraesthesia—Etoposide—lung cancer	0.00119	0.00119	CcSEcCtD
Gadoteridol—Loss of consciousness—Docetaxel—lung cancer	0.00118	0.00118	CcSEcCtD
Gadoteridol—Dyspnoea—Etoposide—lung cancer	0.00118	0.00118	CcSEcCtD
Gadoteridol—Cough—Docetaxel—lung cancer	0.00117	0.00117	CcSEcCtD
Gadoteridol—Hypersensitivity—Irinotecan—lung cancer	0.00117	0.00117	CcSEcCtD
Gadoteridol—Convulsion—Docetaxel—lung cancer	0.00116	0.00116	CcSEcCtD
Gadoteridol—Paraesthesia—Paclitaxel—lung cancer	0.00116	0.00116	CcSEcCtD
Gadoteridol—Hypertension—Docetaxel—lung cancer	0.00116	0.00116	CcSEcCtD
Gadoteridol—Dyspnoea—Paclitaxel—lung cancer	0.00115	0.00115	CcSEcCtD
Gadoteridol—Chest pain—Docetaxel—lung cancer	0.00114	0.00114	CcSEcCtD
Gadoteridol—Nausea—Vinorelbine—lung cancer	0.00114	0.00114	CcSEcCtD
Gadoteridol—Body temperature increased—Cisplatin—lung cancer	0.00114	0.00114	CcSEcCtD
Gadoteridol—Pain—Etoposide—lung cancer	0.00113	0.00113	CcSEcCtD
Gadoteridol—Dry mouth—Docetaxel—lung cancer	0.00112	0.00112	CcSEcCtD
Gadoteridol—Pain—Paclitaxel—lung cancer	0.00111	0.00111	CcSEcCtD
Gadoteridol—Anaphylactic shock—Docetaxel—lung cancer	0.0011	0.0011	CcSEcCtD
Gadoteridol—Oedema—Docetaxel—lung cancer	0.0011	0.0011	CcSEcCtD
Gadoteridol—Pruritus—Gemcitabine—lung cancer	0.00109	0.00109	CcSEcCtD
Gadoteridol—Feeling abnormal—Etoposide—lung cancer	0.00109	0.00109	CcSEcCtD
Gadoteridol—Diarrhoea—Irinotecan—lung cancer	0.00109	0.00109	CcSEcCtD
Gadoteridol—Shock—Docetaxel—lung cancer	0.00108	0.00108	CcSEcCtD
Gadoteridol—Feeling abnormal—Paclitaxel—lung cancer	0.00107	0.00107	CcSEcCtD
Gadoteridol—Hypersensitivity—Cisplatin—lung cancer	0.00106	0.00106	CcSEcCtD
Gadoteridol—Diarrhoea—Gemcitabine—lung cancer	0.00106	0.00106	CcSEcCtD
Gadoteridol—Dizziness—Irinotecan—lung cancer	0.00105	0.00105	CcSEcCtD
Gadoteridol—Urticaria—Etoposide—lung cancer	0.00105	0.00105	CcSEcCtD
Gadoteridol—Abdominal pain—Etoposide—lung cancer	0.00104	0.00104	CcSEcCtD
Gadoteridol—Body temperature increased—Etoposide—lung cancer	0.00104	0.00104	CcSEcCtD
Gadoteridol—Tinnitus—Methotrexate—lung cancer	0.00104	0.00104	CcSEcCtD
Gadoteridol—Sweating—Doxorubicin—lung cancer	0.00103	0.00103	CcSEcCtD
Gadoteridol—Urticaria—Paclitaxel—lung cancer	0.00103	0.00103	CcSEcCtD
Gadoteridol—Hypotension—Docetaxel—lung cancer	0.00102	0.00102	CcSEcCtD
Gadoteridol—Abdominal pain—Paclitaxel—lung cancer	0.00102	0.00102	CcSEcCtD
Gadoteridol—Body temperature increased—Paclitaxel—lung cancer	0.00102	0.00102	CcSEcCtD
Gadoteridol—Vomiting—Irinotecan—lung cancer	0.00101	0.00101	CcSEcCtD
Gadoteridol—Rash—Irinotecan—lung cancer	0.001	0.001	CcSEcCtD
Gadoteridol—Dermatitis—Irinotecan—lung cancer	0.001	0.001	CcSEcCtD
Gadoteridol—Headache—Irinotecan—lung cancer	0.000994	0.000994	CcSEcCtD
Gadoteridol—Diarrhoea—Cisplatin—lung cancer	0.000986	0.000986	CcSEcCtD
Gadoteridol—Paraesthesia—Docetaxel—lung cancer	0.000985	0.000985	CcSEcCtD
Gadoteridol—Vomiting—Gemcitabine—lung cancer	0.000983	0.000983	CcSEcCtD
Gadoteridol—Bradycardia—Doxorubicin—lung cancer	0.000981	0.000981	CcSEcCtD
Gadoteridol—Dyspnoea—Docetaxel—lung cancer	0.000978	0.000978	CcSEcCtD
Gadoteridol—Rash—Gemcitabine—lung cancer	0.000975	0.000975	CcSEcCtD
Gadoteridol—Dermatitis—Gemcitabine—lung cancer	0.000974	0.000974	CcSEcCtD
Gadoteridol—Hypersensitivity—Etoposide—lung cancer	0.000972	0.000972	CcSEcCtD
Gadoteridol—Erythema—Methotrexate—lung cancer	0.000969	0.000969	CcSEcCtD
Gadoteridol—Headache—Gemcitabine—lung cancer	0.000968	0.000968	CcSEcCtD
Gadoteridol—Rhinitis—Doxorubicin—lung cancer	0.000966	0.000966	CcSEcCtD
Gadoteridol—Hypersensitivity—Paclitaxel—lung cancer	0.000953	0.000953	CcSEcCtD
Gadoteridol—Dysgeusia—Methotrexate—lung cancer	0.000949	0.000949	CcSEcCtD
Gadoteridol—Nausea—Irinotecan—lung cancer	0.000943	0.000943	CcSEcCtD
Gadoteridol—Pain—Docetaxel—lung cancer	0.000938	0.000938	CcSEcCtD
Gadoteridol—Pruritus—Etoposide—lung cancer	0.000934	0.000934	CcSEcCtD
Gadoteridol—Nausea—Gemcitabine—lung cancer	0.000918	0.000918	CcSEcCtD
Gadoteridol—Vomiting—Cisplatin—lung cancer	0.000916	0.000916	CcSEcCtD
Gadoteridol—Pruritus—Paclitaxel—lung cancer	0.000916	0.000916	CcSEcCtD
Gadoteridol—Rash—Cisplatin—lung cancer	0.000908	0.000908	CcSEcCtD
Gadoteridol—Dermatitis—Cisplatin—lung cancer	0.000908	0.000908	CcSEcCtD
Gadoteridol—Feeling abnormal—Docetaxel—lung cancer	0.000904	0.000904	CcSEcCtD
Gadoteridol—Diarrhoea—Etoposide—lung cancer	0.000903	0.000903	CcSEcCtD
Gadoteridol—Ill-defined disorder—Methotrexate—lung cancer	0.000899	0.000899	CcSEcCtD
Gadoteridol—Tinnitus—Doxorubicin—lung cancer	0.000898	0.000898	CcSEcCtD
Gadoteridol—Flushing—Doxorubicin—lung cancer	0.000894	0.000894	CcSEcCtD
Gadoteridol—Diarrhoea—Paclitaxel—lung cancer	0.000885	0.000885	CcSEcCtD
Gadoteridol—Malaise—Methotrexate—lung cancer	0.000874	0.000874	CcSEcCtD
Gadoteridol—Dizziness—Etoposide—lung cancer	0.000873	0.000873	CcSEcCtD
Gadoteridol—Abdominal pain—Docetaxel—lung cancer	0.000867	0.000867	CcSEcCtD
Gadoteridol—Body temperature increased—Docetaxel—lung cancer	0.000867	0.000867	CcSEcCtD
Gadoteridol—Dizziness—Paclitaxel—lung cancer	0.000856	0.000856	CcSEcCtD
Gadoteridol—Nausea—Cisplatin—lung cancer	0.000856	0.000856	CcSEcCtD
Gadoteridol—Cough—Methotrexate—lung cancer	0.000845	0.000845	CcSEcCtD
Gadoteridol—Convulsion—Methotrexate—lung cancer	0.000839	0.000839	CcSEcCtD
Gadoteridol—Vomiting—Etoposide—lung cancer	0.000839	0.000839	CcSEcCtD
Gadoteridol—Erythema—Doxorubicin—lung cancer	0.000839	0.000839	CcSEcCtD
Gadoteridol—Rash—Etoposide—lung cancer	0.000832	0.000832	CcSEcCtD
Gadoteridol—Dermatitis—Etoposide—lung cancer	0.000831	0.000831	CcSEcCtD
Gadoteridol—Headache—Etoposide—lung cancer	0.000827	0.000827	CcSEcCtD
Gadoteridol—Chest pain—Methotrexate—lung cancer	0.000825	0.000825	CcSEcCtD
Gadoteridol—Vomiting—Paclitaxel—lung cancer	0.000823	0.000823	CcSEcCtD
Gadoteridol—Dysgeusia—Doxorubicin—lung cancer	0.000821	0.000821	CcSEcCtD
Gadoteridol—Rash—Paclitaxel—lung cancer	0.000816	0.000816	CcSEcCtD
Gadoteridol—Dermatitis—Paclitaxel—lung cancer	0.000815	0.000815	CcSEcCtD
Gadoteridol—Discomfort—Methotrexate—lung cancer	0.000815	0.000815	CcSEcCtD
Gadoteridol—Headache—Paclitaxel—lung cancer	0.000811	0.000811	CcSEcCtD
Gadoteridol—Hypersensitivity—Docetaxel—lung cancer	0.000808	0.000808	CcSEcCtD
Gadoteridol—Anaphylactic shock—Methotrexate—lung cancer	0.000791	0.000791	CcSEcCtD
Gadoteridol—Nausea—Etoposide—lung cancer	0.000784	0.000784	CcSEcCtD
Gadoteridol—Ill-defined disorder—Doxorubicin—lung cancer	0.000778	0.000778	CcSEcCtD
Gadoteridol—Pruritus—Docetaxel—lung cancer	0.000776	0.000776	CcSEcCtD
Gadoteridol—Nausea—Paclitaxel—lung cancer	0.000769	0.000769	CcSEcCtD
Gadoteridol—Hyperhidrosis—Methotrexate—lung cancer	0.000764	0.000764	CcSEcCtD
Gadoteridol—Malaise—Doxorubicin—lung cancer	0.000756	0.000756	CcSEcCtD
Gadoteridol—Syncope—Doxorubicin—lung cancer	0.000752	0.000752	CcSEcCtD
Gadoteridol—Diarrhoea—Docetaxel—lung cancer	0.000751	0.000751	CcSEcCtD
Gadoteridol—Hypotension—Methotrexate—lung cancer	0.000739	0.000739	CcSEcCtD
Gadoteridol—Loss of consciousness—Doxorubicin—lung cancer	0.000737	0.000737	CcSEcCtD
Gadoteridol—Cough—Doxorubicin—lung cancer	0.000732	0.000732	CcSEcCtD
Gadoteridol—Convulsion—Doxorubicin—lung cancer	0.000727	0.000727	CcSEcCtD
Gadoteridol—Dizziness—Docetaxel—lung cancer	0.000725	0.000725	CcSEcCtD
Gadoteridol—Hypertension—Doxorubicin—lung cancer	0.000724	0.000724	CcSEcCtD
Gadoteridol—Chest pain—Doxorubicin—lung cancer	0.000714	0.000714	CcSEcCtD
Gadoteridol—Anxiety—Doxorubicin—lung cancer	0.000712	0.000712	CcSEcCtD
Gadoteridol—Paraesthesia—Methotrexate—lung cancer	0.00071	0.00071	CcSEcCtD
Gadoteridol—Discomfort—Doxorubicin—lung cancer	0.000706	0.000706	CcSEcCtD
Gadoteridol—Dyspnoea—Methotrexate—lung cancer	0.000705	0.000705	CcSEcCtD
Gadoteridol—Dry mouth—Doxorubicin—lung cancer	0.000698	0.000698	CcSEcCtD
Gadoteridol—Vomiting—Docetaxel—lung cancer	0.000697	0.000697	CcSEcCtD
Gadoteridol—Rash—Docetaxel—lung cancer	0.000692	0.000692	CcSEcCtD
Gadoteridol—Dermatitis—Docetaxel—lung cancer	0.000691	0.000691	CcSEcCtD
Gadoteridol—Headache—Docetaxel—lung cancer	0.000687	0.000687	CcSEcCtD
Gadoteridol—Oedema—Doxorubicin—lung cancer	0.000685	0.000685	CcSEcCtD
Gadoteridol—Anaphylactic shock—Doxorubicin—lung cancer	0.000685	0.000685	CcSEcCtD
Gadoteridol—Pain—Methotrexate—lung cancer	0.000676	0.000676	CcSEcCtD
Gadoteridol—Shock—Doxorubicin—lung cancer	0.000674	0.000674	CcSEcCtD
Gadoteridol—Hyperhidrosis—Doxorubicin—lung cancer	0.000662	0.000662	CcSEcCtD
Gadoteridol—Nausea—Docetaxel—lung cancer	0.000652	0.000652	CcSEcCtD
Gadoteridol—Feeling abnormal—Methotrexate—lung cancer	0.000651	0.000651	CcSEcCtD
Gadoteridol—Hypotension—Doxorubicin—lung cancer	0.00064	0.00064	CcSEcCtD
Gadoteridol—Urticaria—Methotrexate—lung cancer	0.000628	0.000628	CcSEcCtD
Gadoteridol—Abdominal pain—Methotrexate—lung cancer	0.000625	0.000625	CcSEcCtD
Gadoteridol—Body temperature increased—Methotrexate—lung cancer	0.000625	0.000625	CcSEcCtD
Gadoteridol—Paraesthesia—Doxorubicin—lung cancer	0.000615	0.000615	CcSEcCtD
Gadoteridol—Dyspnoea—Doxorubicin—lung cancer	0.00061	0.00061	CcSEcCtD
Gadoteridol—Pain—Doxorubicin—lung cancer	0.000585	0.000585	CcSEcCtD
Gadoteridol—Hypersensitivity—Methotrexate—lung cancer	0.000582	0.000582	CcSEcCtD
Gadoteridol—Feeling abnormal—Doxorubicin—lung cancer	0.000564	0.000564	CcSEcCtD
Gadoteridol—Pruritus—Methotrexate—lung cancer	0.000559	0.000559	CcSEcCtD
Gadoteridol—Urticaria—Doxorubicin—lung cancer	0.000544	0.000544	CcSEcCtD
Gadoteridol—Abdominal pain—Doxorubicin—lung cancer	0.000541	0.000541	CcSEcCtD
Gadoteridol—Body temperature increased—Doxorubicin—lung cancer	0.000541	0.000541	CcSEcCtD
Gadoteridol—Diarrhoea—Methotrexate—lung cancer	0.000541	0.000541	CcSEcCtD
Gadoteridol—Dizziness—Methotrexate—lung cancer	0.000523	0.000523	CcSEcCtD
Gadoteridol—Hypersensitivity—Doxorubicin—lung cancer	0.000504	0.000504	CcSEcCtD
Gadoteridol—Vomiting—Methotrexate—lung cancer	0.000503	0.000503	CcSEcCtD
Gadoteridol—Rash—Methotrexate—lung cancer	0.000498	0.000498	CcSEcCtD
Gadoteridol—Dermatitis—Methotrexate—lung cancer	0.000498	0.000498	CcSEcCtD
Gadoteridol—Headache—Methotrexate—lung cancer	0.000495	0.000495	CcSEcCtD
Gadoteridol—Pruritus—Doxorubicin—lung cancer	0.000484	0.000484	CcSEcCtD
Gadoteridol—Nausea—Methotrexate—lung cancer	0.00047	0.00047	CcSEcCtD
Gadoteridol—Diarrhoea—Doxorubicin—lung cancer	0.000468	0.000468	CcSEcCtD
Gadoteridol—Dizziness—Doxorubicin—lung cancer	0.000453	0.000453	CcSEcCtD
Gadoteridol—Vomiting—Doxorubicin—lung cancer	0.000435	0.000435	CcSEcCtD
Gadoteridol—Rash—Doxorubicin—lung cancer	0.000432	0.000432	CcSEcCtD
Gadoteridol—Dermatitis—Doxorubicin—lung cancer	0.000431	0.000431	CcSEcCtD
Gadoteridol—Headache—Doxorubicin—lung cancer	0.000429	0.000429	CcSEcCtD
Gadoteridol—Nausea—Doxorubicin—lung cancer	0.000407	0.000407	CcSEcCtD
